Related Experiment Video
Updated: Jun 24, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma
Letícia Ferreira Alves1, Leonardo Augusto Marson1, Micheli Severo Sielski1
1Department of Structural and Functional Biology, Institute of Biology, Universidade Estadual de Campinas, Brazil.
Background:
In previous studies, we demonstrated the downregulation of several miRNAs from the DLK1-DIO3 genomic region in papillary thyroid carcinoma (PTC). Due to the large number of miRNAs within this region, the individual contribution of these molecules to PTC development and progression remains unclear.
Objective:
In this study, we aimed to clarify the contribution of DLK1-DIO3-derived miRNAs to PTC.
Methods:
We used different computational approaches and in vitro resources to assess the biological processes and signaling pathways potentially modulated by these miRNAs.
Results:
Our analysis suggests that, out of more than 100 mature miRNAs originated from the DLK1-DIO3 region, a set of 12 miRNAs accounts for most of the impact on PTC development and progression, cooperating to modulate distinct cancer-relevant biological processes, such as cell migration, extracellular matrix remodeling, and signal transduction. The restoration of the expression of one of these miRNAs (miR-485-5p) in a BRAFT199A-positive PTC cell line impaired proliferation and migration, suppressing the expression of GAB2 and RAC1, validated miR-485-5p targets.
Conclusions:
Overall, our results shed light on the role of the DLK1-DIO3 region, which harbors promising tumor suppressor miRNAs in thyroid cancer, and open prospects for the functional exploration of these miRNAs as therapeutic targets for PTC.
Insights
A specific set of 12 microRNAs (miRNAs) from the DLK1-DIO3 region significantly impacts papillary thyroid carcinoma (PTC) progression. Restoring one miRNA, miR-485-5p, inhibited PTC cell proliferation and migration.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- Previous studies identified downregulated microRNAs (miRNAs) from the DLK1-DIO3 genomic region in papillary thyroid carcinoma (PTC).
- The specific roles of individual miRNAs within this large cluster in PTC development were previously unclear.
Purpose of the Study:
- To elucidate the contribution of DLK1-DIO3-derived miRNAs to papillary thyroid carcinoma.
- To identify key miRNAs and their targeted pathways involved in PTC pathogenesis.
Main Methods:
- Utilized computational approaches and in vitro models to analyze miRNA functions.
- Assessed biological processes and signaling pathways modulated by DLK1-DIO3 miRNAs.
- Validated targets and functional effects of specific miRNAs in PTC cell lines.
Main Results:
- Identified a subset of 12 mature miRNAs from the DLK1-DIO3 region responsible for most of the impact on PTC development and progression.
- These miRNAs collectively modulate critical cancer processes including cell migration, extracellular matrix remodeling, and signal transduction.
- Restoration of miR-485-5p expression in a BRAFT199A-positive PTC cell line suppressed proliferation and migration by downregulating GAB2 and RAC1.
Conclusions:
- The DLK1-DIO3 genomic region contains tumor suppressor miRNAs relevant to thyroid cancer.
- These findings highlight the potential of DLK1-DIO3-derived miRNAs as therapeutic targets for papillary thyroid carcinoma.
More Related Videos
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
lncRNA - Long Non-coding RNAs
MicroRNAs
Abnormal Proliferation
Non-LTR Retrotransposons

